Bovie Medical to Present at Craig-Hallum Alpha Select Conference

CLEARWATER, Fla.--()--Bovie Medical Corporation (“Bovie” or the “Company”) (NYSE:BVX), a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, announced today that Robert L. Gershon, Chief Executive Officer of the Company, will present at the 6th Annual Craig-Hallum Alpha Select Conference.

Mr. Gershon will present at noon on Thursday, September 17, 2015, at the Convene Conference Center in New York. During his presentation, Mr. Gershon will discuss the latest developments for J-Plasma®, Bovie’s transformational surgical product, which enables surgeons to operate with greater precision on and around delicate structures with minimal thermal spread. The presentation will be webcast at http://www.boviemedical.com/financials.asp

Bovie Medical’s management team will also conduct one-on-one meetings. Interested investors attending the conference may arrange a meeting by contacting their Craig-Hallum representative.

About Bovie Medical Corporation

Bovie Medical Corporation is a leading maker of medical devices and supplies as well as the developer of J-Plasma®, a patented new plasma-based surgical product for cutting and coagulation. J-Plasma®, utilizes a helium ionization process to produce a stable, focused beam of ionized gas that provides surgeons with greater precision, minimal invasiveness and an absence of conductive currents through the patient during surgery. Bovie Medical Corporation is also a leader in the manufacture of a range of electrosurgical products and technologies, marketed through both private labels and the Company’s own well-respected brands (Bovie®, Aaron®, IDS™ and ICON™) to distributors worldwide. The Company also leverages its expertise through original equipment manufacturing (OEM) agreements with other medical device manufacturers. For further information about the Company’s current and new products, please refer to the Investor Relations section of Bovie Medical Corporation’s website www.boviemed.com.

Contacts

Investor Relations:
MBS Value Partners
Hugh Collins, 212-223-4632
investor.relations@boviemed.com

Recent Stories

RSS feed for Bovie Medical Corporation

Bovie Medical Corporation